Forecast
22
Laboratories ( NABL )
RELATED REPORTS
RELATED REPORTS
SR . NO . REPORT TITLE PUBLISHED DATE
1
IN VITRO DIAGNOSTICS ( IVD ) MARKET By Product ( instruments , Reagents , Software , Service ) Technology ( Immunoassay , Clinical Chemistry , Molecular Diagnostics , Hematology ) by Application ( Diabetes , Cancer , Cardiology , Autoimmune Diseases ) - Forecast to 2020
July 2015
2
MOLECULAR DIAGNOSTICS MARKET By Application ( Infectious Disease ( HIV , HPV , TB ), Oncology , Genetics , Microbiology ), Technology ( PCR , Microarray , DNA Sequencing ), End User ( Hospital , Laboratories ), Product ( Instruments , Reagent , Software ) - Forecast to 2020
November 2015
U . S . In Vitro Diagnostics ( IVD ) Market – Forecast to 2020
1.3.1 MARKETS COVERED This research report categorizes the in vitro diagnostics ( IVD ) market into the following segments :
FIGURE 1 U . S . IN VITRO DIAGNOSTICS MARKET
BY PRODUCTS & SERVICES
• Instruments
• Fully Automated
• Semi Automated
• Others
• Reagents
• Data Management Software
• Services
Note 1 : Other IVD technologies include flow cytometry , In-situ hybridization and Fluorescence in situ hybridization ( FISH ), and selfblood glucose monitoring .
2 : Other applications include blood analysis tests , urine analysis tests , pregnancy tests , and general clinical applications .
3 : Other end users ( include physician office laboratories , blood banks , home health agencies , nursing homes , ambulatory surgical centers , and patient self-testing )
U . S . In Vitro Diagnostics End User Market , by Region
• Clinical Laboratories / Independent Laboratories Market , by Region
• South
• West
• Midwest
• Northeast
• Hospital Laboratories Market , by Region
• South
• West
• Midwest
• Northeast
U . S . IN VITRO DIAGNOSTICS MARKET
BY TECHNOLOGY
• Clinical Chemistry
• Immunoassays / Immunoch emistry
• Hematology
• Coagulation and Hemostasis
• Microbiology
• Molecular Diagnostics
• Other IVD Technologies
BY APPLICATION
• Diabetes
• Bone & Mineral Disorders
• Infectious Diseases
• Oncology / Cancer
• Endocrine Disorders
• Cardiovascular Disorders
• Pulmonary Disorders
• Autoimmune Diseases
• Other Applications
BY END USER
• Clinical / Independent Laboratories
• Large-sized Laboratories / Refere nce Laboratories
• Medium-sized Laboratories
• Small-sized Laboratories
• Hospital Laboratories
• Other End Users
U . S . In Vitro Diagnostics ( IVD ) Market – Forecast to 2020
1.3.2 YEARS CONSIDERED FOR THE STUDY
2013
HISTORICAL YEAR
Note : For market estimates , the calendar year has been considered ; whereas , for company profiles , the fiscal year has been considered .
1.4 CURRENCY The currency used in the report is USD ($), with market size indicated in USD million .
• For companies reporting their revenues in USD , the revenues were picked from their annual reports
• For companies that reported their revenues in other currencies , the average annual currency conversion rate was used for that particular year to convert the value to USD
1.5 LIMITATIONS
• The company developments not reported in the public domain are not included in the report
• The report does not provide the volume market for devices / products used during the IVD
procedure
1.6 STAKEHOLDERS
2014
BASE YEAR
• IVD Product Manufacturers
• Group Purchase Organizations ( GPOs )
• OEM Manufacturers
• Pathologists and Pathology Laboratories
• Distributors of IVD Products
• Hospitals and Clinics
• Healthcare Institutions
• Research Institutes
2015-e
ESTIMATED YEAR
2015-2020
U . S . In Vitro Diagnostics ( IVD ) Market – Forecast to 2020
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FORECAST PERIOD
This research study involved the extensive usage of both primary and secondary data sources . The research process involved the study of various factors affecting the industry , including the regulatory landscape ; competitive scenario ; historic data ; current trends in the market ; technological innovation and upcoming technologies ; and market drivers , restraints , opportunities , and challenges .
The following illustrative figure shows the market research methodology applied in making this report on the U . S . in vitro diagnostics ( IVD ) market .
FIGURE 2 RESEARCH DESIGN
HISTORICAL DATA FOR THE U . S . IN VITRO
MARKET
DIAGNOSTICS
INFLUENCING FACTORS ( Market Trends and Dynamics )
FORECAST PERIOD ( 2015 – 2020 )
COST OF PRODUCTS AND DIAGNOSTIC TESTS COMPANY REVENUES & R & D EXPENSES
MARKET DRIVERS :
• Rapid growth in the geriatric population and increasing incidence of chronic diseases in the U . S .
• Increasing adoption of pointof-care testing
• Growing awareness on personalized medicine
• Rise in reagent rental agreements
• Implementation of Affordable Care Act ( ACA )
• Increasing adoption of automated instruments and automation in laboratories
HISTORICAL DATA OF THE MARKET
IMPACT ANALYSIS OF MARKET TRENDS
MARKET SHARE ANALYSIS COMPETITIVE LANDSCAPE
MARKET OPPORTUNITY :
• Unfavorable reimbursement • New range of condition-specific scenario tests and markers with advances in
• Rising healthcare cost and low genomics and proteomics budget of laboratories limits the adoption of novel disease
MARKET CHALLENGE : diagnostic tests
• Stringent regulatory framework
• NEW PRODUCT LAUNCHES : Accounted for 43 % of the overall developments during
• COLLABORATIONS , PARTNERSHIPS & AGREEMENTS : Accounted for 23 % of the
• APPROVALS : Accounted for 17 % of the overall developments during 2012 to 2016
• MERGERS & ACQUISITIONS : Accounted for 12 % of the overall developments during
GEOGRAPHICAL ANALYSIS : Market dynamics and business environment in the
MARKET RESTRAINTS :
U . S .
U . S . IVD MARKET SIZE & FORECAST :
© MarketsandMarkets
• Market Research and Consulting Firms
• Venture Capitalists and Investors
15
• By Products & Services
2012 to 2016
overall developments during 2012 to 2016
2012 to 2016
DEMAND SIDE
U . S . In Vitro Diagnostics ( IVD ) Market – Forecast to 2020
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
After arriving at the market size from the market size estimation process explained above , the U . S . IVD market was divided into several segments and subsegments . In order to complete the overall market engineering process and arrive at the exact statistics for all the segments and subsegments , data triangulation and market breakdown procedures were employed , wherever applicable .
The following figure shows the market validation sources structure and the data triangulation methodology implemented in the market engineering process for making this report .
FIGURE 5 DATA TRIANGULATION METHODOLOGY
PRIMARY SOURCES
INTERVIEWS WITH :
• Hospitals
• Clinics
• Laboratories
• By Application
• By End User
• By Technology
INTERVIEWS WITH :
• Presidents , CEOs , Vice Presidents , Directors , General Managers , Heads of IVD Business Segments , and Senior Managers
ARRIVE AT THE MARKET SIZE , SHARE , AND CAGR FOR THE
U . S . IVD MARKET
• Product / Sales / Marketing / B usiness / Development Client Portfolio Managers or Specialists , Distributors / Suppliers / Channel
Intelligence Consultants
SUPPLY SIDE
Partners , and Business
PRIMARY SOURCE
MnM KNOW *
DATA TRIANGULATION
SECONDARY SOURCES
Annual Reports , Presentations , Websites , and Press Releases of Top Players ; News Articles ; Journals ; and Paid Databases
16
SECONDARY SOURCE
• American Association for Clinical Chemistry ( AACC )
• American Diabetes Association ( ADA )
• National Accreditation Board for Testing and Calibration
© MarketsandMarkets
© MarketsandMarkets
Key Players Competitive Landscape
Drivers and Restraints
INFORMATION SOURCED
Opportunities and Challenges
• Centers for Disease Control and Prevention ( CDC )
• World Health Organization ( WHO )
Market Size ( 2015 ) and Market Share ( 2014 )
MnM KNOW * stands for MarketsandMarkets ’ ' Knowledge Asset Management ' framework . In this context , it stands for existing market research knowledge repository of over 5,000 granular markets , our flagship competitive intelligence and market research platform " RT ", subject matter experts , and independent consultants . MnM KNOW acts as an independent source that helps us validate information gathered from primary and secondary sources .
© MarketsandMarkets
17 sales @ marketsandmarkets . com www . marketsandmarkets . com
25